News
Optimizing perioperative cardiac risk assessment and management for noncardiac surgery
November 30, 2021
What is the sum of evidence supporting perioperative cardiac risk assessment and risk reduction?
News
Predicting cardiac shock mortality in the ICU
November 23, 2021
Including biventricular dysfunction as assessed using transthoracic echocardiography improves clinical risk stratification.
News
Advanced CKD doesn’t derail empagliflozin in EMPEROR-preserved
November 19, 2021
Study shows empagliflozin led to a consistent, significant relative risk reduction compared with placebo in the primary endpoint.
News
Empagliflozin a winner in challenging arena of stabilized acute HF
November 19, 2021
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of their ejection fraction, says an expert observer.
News
Early rhythm control in atrial fibrillation (EAST-AFNET trial)
November 17, 2021
Is rhythm control superior to rate control in treating early atrial fibrillation (AFib)?
News
EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
November 17, 2021
A landmark trial proved empagliflozin’s efficacy in HFpEF, but many patients had “moderately reduced” EFs. The findings hold up even without them.
News
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
November 17, 2021
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a phase 3 trial.
News
EHRs have no impact on inpatient heart failure clinical choices or outcomes
November 15, 2021
Relative to usual care, prognostic information at the bedside provided no advantage for heart failure care.
News
Troponin elevation at any age is a risk for cardiac mortality
November 15, 2021
Is an elevated troponin value associated with increased mortality, regardless of age?
News
BP Track: Blood pressure control rates dropped during pandemic
November 14, 2021
Data culled from 24 health systems showed lower rates of blood pressure control during the COVID-19 pandemic.